Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 8/20 | 0.42 |
| ▸ | NPY1R | P25929 | 6/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.42 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.41 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.41 |
| ▸ | GRPR | P30550 | 1/20 | 0.40 |
| ▸ | GLP1R | P43220 | 1/20 | 0.40 |
| ▸ | GCGR | P47871 | 1/20 | 0.40 |
| ▸ | GIPR | P48546 | 1/20 | 0.40 |
| ▸ | NPY2R | P49146 | 2/20 | 0.39 |
| ▸ | FNTA | P49354 | 3/20 | 0.38 |
| ▸ | FNTB | P49356 | 3/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.38 |
| ▸ | APLNR | P35414 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31433321 | 0.98 | NPY4R (0.42) | NPY4RNPY1RNPY5RIL23RMAPK8 | |
| SCHEMBL31433299 | 0.93 | MAPK8 (0.49) | NPY4RNPY1RNPY5RIL23RMAPK8 | |
| SCHEMBL29777857 | 0.90 | GLP1R (0.47) | NPY4RNPY1RNPY5RIL23RGLP1R | |
| SCHEMBL31433470 | 0.87 | MAPK8 (0.51) | NPY4RNPY1RNPY5RMAPK8MAPK9 | |
| SCHEMBL29777720 | 0.87 | GLP1R (0.44) | NPY4RNPY1RNPY5RIL23RGLP1R | |
| SCHEMBL31433180 | 0.86 | MAPK8 (0.50) | NPY4RNPY1RNPY5RMAPK8MAPK9 | |
| SCHEMBL31433297 | 0.86 | MAPK8 (0.50) | NPY4RNPY1RNPY5RMAPK8MAPK9 | |
| SCHEMBL31433317 | 0.85 | APLNR (0.52) | MAPK8MAPK9MAPK10APLNR | |
| SCHEMBL30693054 | 0.84 | NPY4R (0.48) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL30262032 | 0.84 | NPY4R (0.56) | NPY4RNPY1RNPY5RIL23RGLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | CALICO LIFE SCIENCES LLC (US) | 2025-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074942-A1 | COMPOSITIONS AND METHODS FOR COVALENT PEPTIDE-BASED MODULATORS OF HLA-E | MICA, CD74, HLA-DRB1 | NPY4R 1616/4885NPY1R 2353/4885NPY5R 3645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.